... References Ovarian Cancer Treatment Options — Ovarian Cancer Research Alliance Chemotherapy for Ovarian Cancer — American Cancer Society Treatment of Invasive Epithelial Ovarian Cancers, by Stage — American Cancer Society Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial — NEJM Evidence Paclitaxel (With Polyoxyethylated Castor Oil) ...
... References Ovarian Cancer Treatment Options — Ovarian Cancer Research Alliance Chemotherapy for Ovarian Cancer — American Cancer Society Treatment of Invasive Epithelial Ovarian Cancers, by Stage — American Cancer Society Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial — NEJM Evidence Paclitaxel (With Polyoxyethylated Castor Oil) ...
... Then, if imaging tests show that the chemotherapy is working and the cancer is shrinking, you may undergo surgery, followed by additional cycles of chemotherapy.People with germ cell or stromal tumors usually receive different chemotherapy drugs. ...
... Then, if imaging tests show that the chemotherapy is working and the cancer is shrinking, you may undergo surgery, followed by additional cycles of chemotherapy.People with germ cell or stromal tumors usually receive different chemotherapy drugs. ...
... Bone Marrow Damage and Secondary CancerIn rare instances, long-lasting damage to bone marrow from chemotherapy can result in types of blood cancer called myelodysplastic syndrome and acute myeloid leukemia.8. Cognitive ImpairmentSometimes called “chemo brain,” cognitive impairment can happen during or after chemotherapy. ...
... Bone Marrow Damage and Secondary CancerIn rare instances, long-lasting damage to bone marrow from chemotherapy can result in types of blood cancer called myelodysplastic syndrome and acute myeloid leukemia.8. Cognitive ImpairmentSometimes called “chemo brain,” cognitive impairment can happen during or after chemotherapy. ...
... This means it combines a chemotherapy drug with a lab-made antibody that helps deliver the drug directly to cancer cells.According to the American Cancer Society, ovarian cancers often have high levels of folate receptor-alpha (FR-alpha) proteins. ...
... This means it combines a chemotherapy drug with a lab-made antibody that helps deliver the drug directly to cancer cells.According to the American Cancer Society, ovarian cancers often have high levels of folate receptor-alpha (FR-alpha) proteins. ...
... Zejula was studied in people who had already gone through platinum-based chemotherapy with good results. Like many other trials studying maintenance therapies, this trial judged success based on progression-free survival (PFS). This term measures how long it takes for a cancer to get worse or come back. ...
... Zejula was studied in people who had already gone through platinum-based chemotherapy with good results. Like many other trials studying maintenance therapies, this trial judged success based on progression-free survival (PFS). This term measures how long it takes for a cancer to get worse or come back. ...
... Side Effects — CancerCare Cancer Treatment Side Effect: Dehydration — The University of Texas MD Anderson Cancer Center Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival — Alcohol Research: Current Reviews Can You Drink Alcohol During Chemotherapy? ...
... Side Effects — CancerCare Cancer Treatment Side Effect: Dehydration — The University of Texas MD Anderson Cancer Center Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival — Alcohol Research: Current Reviews Can You Drink Alcohol During Chemotherapy? ...
... Case Report and Review of the Literature — Anticancer Research Survival Rates for Ovarian Cancer — American Cancer Society Overall Survival and Post-Progression Survival Are Potent Endpoint in Phase III Trials of Second/Third-Line Chemotherapy for Advanced or Recurrent Epithelial Ovarian Cancer — Journal of Cancer Priority Symptoms Identified in Recurrent ...
... Case Report and Review of the Literature — Anticancer Research Survival Rates for Ovarian Cancer — American Cancer Society Overall Survival and Post-Progression Survival Are Potent Endpoint in Phase III Trials of Second/Third-Line Chemotherapy for Advanced or Recurrent Epithelial Ovarian Cancer — Journal of Cancer Priority Symptoms Identified in Recurrent ...